Acasti Pharma reported $1.96M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acasti Pharma USD 1.96M 180K Sep/2025
Addus HomeCare USD 77.18M 2.19M Dec/2025
Amarin USD 18.97M 1.03M Dec/2025
Cassava Sciences USD 6.66M 1.24M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Option Care Health USD 172.14M 33K Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Tilray USD 24.85M 1.7M Sep/2025